The Role of GLP-1 Therapies in Treating Obesity: A Comprehensive Overview
By Dr.Kijakarn Junda, 2025
Introduction Obesity has become a global public health crisis, affecting over 1 billion people and driving significant morbidity, mortality, and economic burden (Celletti et al., 2025). The World Health Organization (WHO) has recognized obesity as a chronic, relapsing disease, emphasizing the need for lifelong care and integrated treatment strategies. Among the emerging solutions, glucagon-like peptide-1 (GLP-1) therapies have gained prominence due to their ability to promote weight loss and improve metabolic health.
Continue reading “The Role of GLP-1 Therapies in Treating Obesity: A Comprehensive Overview”